文献速递腹部CTMR

对比增强CT联合非增强MRI对结直肠癌肝转移的诊断效能

Diagnostic Performance of Contrast Enhanced CT Alone or in Combination with (Non-)Enhanced MRI for Colorectal Liver Metastasis.
PubMed 文献 · Acad Radiol · 2022-12-05

结果显示CE-CT联合NE-MRI的检出率和AUC均优于单独CE-CT,且与CE-CT联合CE-MRI相当,提示联合非增强MRI可提升诊断性能。

要点

  • CE-CT联合NE-MRI对结直肠癌肝转移的检出率及AUC优于单独CE-CT。
  • 联合NE-MRI与联合CE-MRI的诊断效能相当,可作为替代方案。
  • 对于小于10mm的病灶,联合NE-MRI的AUC仍显著优于单独CE-CT。

局限性

  • 回顾性设计可能存在选择偏倚。
  • 单中心研究,结果外推需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

RATIONALE AND OBJECTIVES: To compare the diagnostic performance of contrast enhanced CT (CE-CT), CE-CT combined with non-enhanced MRI (NE-MRI) or contrast enhanced MRI (CE-MRI) for colorectal liver metastasis (CRLM).

MATERIALS AND METHODS: Sixty-six colorectal cancer patients with 198 focal liver lesions who underwent preoperative abdominal CE-CT and MRI examinations were included respectively. The images were assessed independently by two readers in three protocols (1: CE-CT, 2: CE-CT+NE-MRI, 3: CE-CT+CE-MRI). The diagnostic performance of each protocol was analyzed by receiver operating characteristic (ROC) curve and the areas under ROC (AUCs) were calculated and compared.

RESULTS: The detection rates of protocol 2 were 90.9%-92.9% for liver lesions and 86.4%-89.6% for CRLM, and both significantly higher than protocol 1 of 82.8%-85.4% and 76.8%-80.8% (p<0.001-0.001), whereas similar to protocol 3 of 91.9%-94.4% and 87.2%-91.2% (p 0.250-1.000). The AUCs of protocol 2 were greater than protocol 1 for all lesions (0.914-0.934 vs. 0.779-0.799, p<0.001) and lesions < 10mm (0.726-0.776 vs. 0.528-0.561, p<0.001), and were not inferior to that of protocol 3 (0.929-0.949 in all lesions and 0.754-0.821 in lesion < 10mm, p 0.053-0.162).

CONCLUSION: CE-CT combined with NE-MRI offered superior diagnostic performance for CRLM compared to CE-CT alone and showed comparable performance to CE-CT combined with CE-MRI.

来源:Acad Radiol,查看原文。版权归原作者所有。

引用

  1. Qiu, Zhu, Wang, et al. Diagnostic Performance of Contrast Enhanced CT Alone or in Combination with (Non-)Enhanced MRI for Colorectal Liver Metastasis. Acad Radiol. 2022. PMID: 36481127. doi:10.1016/j.acra.2022.11.011

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。